Skip to content

Tyra Biosciences, Inc.

TYRA · XNAS

CIK 1863127fmd_0AG5THR3GP76HA6C8146C861Y0Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading
FinancialMD terminal